We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress
Sign In
Advertise with Us

Download Mobile App

PSMA PET Aids Decision Making in Prostate Cancer Treatment

By MedImaging International staff writers
Posted on 28 Mar 2023
Print article
Image: Heat map of prostate bed PSMA PET recurrences (Photo courtesy of UMiami Health System)
Image: Heat map of prostate bed PSMA PET recurrences (Photo courtesy of UMiami Health System)

Within 10 years after undergoing radical prostatectomy, approximately one-third of prostate cancer patients experience disease progression. Salvage radiation therapy (SRT) is a promising treatment option for these patients. However, current SRT follows contouring guidelines based on expert consensus, which do not utilize the information available from advanced imaging techniques like PSMA PET. Now, a recent study utilizing detailed PSMA PET mapping of cancer recurrence in the prostate bed has revealed that the current radiotherapy contouring guidelines miss a significant number of lesions and may result in unnecessary irradiation of healthy tissues.

The study by researchers at the University of Miami Health System (Miami, FL, USA) and University of California, Los Angeles (UCLA, Los Angeles, CA, USA) involved the use of PSMA PET imaging to examine the recurrence patterns of the prostate bed in 127 prostate cancer patients with PSA persistence or biochemical recurrence following radical prostatectomy. Using the RTOG contouring guidelines, the researchers evaluated the location of recurrent lesions for each PSMA PET scan and established the clinical target volume (CTV). The lesions were subsequently classified as completely covered, partially covered, or not covered by the contouring guidelines. Of the patients, 53% had their recurrent lesions completely covered in the CTV, 34% were partially covered, while 13% were not covered at all. Additionally, some regions in the CTV showed no evidence of lesions. Following the study, the researchers are now advocating for a reevaluation of the prostate bed contouring guidelines to enhance patient outcomes.

“We hope this study will help redefine prostate bed contouring guidelines for SRT to improve the outcomes of patients receiving radiotherapy post-radical surgery,” said Ida Sonni, MD, nuclear medicine physician and academic researcher in the Department of Radiological Sciences at the University of California, Los Angeles. “Our work confirms the crucial and growing role that nuclear medicine and molecular imaging have in guiding decision-making for cancer treatment. Nuclear medicine plays an essential part in the multidisciplinary management of patients with prostate cancer and facilitates the use of individualized, tailored treatments, which ultimately benefit all our patients.”

Related Links:
University of Miami Health System 

Gold Member
Solid State Kv/Dose Multi-Sensor
Ultrasound Needle Guide
Ultra-Pro II
Ultrasound Table
Ergonomic Advantage (EA) Line
Portable Radiology System

Print article



view channel
Image: The emerging role of MRI alongside PSA testing is redefining prostate cancer diagnostics (Photo courtesy of 123RF)

Combining MRI with PSA Testing Improves Clinical Outcomes for Prostate Cancer Patients

Prostate cancer is a leading health concern globally, consistently being one of the most common types of cancer among men and a major cause of cancer-related deaths. In the United States, it is the most... Read more

Nuclear Medicine

view channel
Image: The new SPECT/CT technique demonstrated impressive biomarker identification (Journal of Nuclear Medicine: doi.org/10.2967/jnumed.123.267189)

New SPECT/CT Technique Could Change Imaging Practices and Increase Patient Access

The development of lead-212 (212Pb)-PSMA–based targeted alpha therapy (TAT) is garnering significant interest in treating patients with metastatic castration-resistant prostate cancer. The imaging of 212Pb,... Read more

Imaging IT

view channel
Image: The new Medical Imaging Suite makes healthcare imaging data more accessible, interoperable and useful (Photo courtesy of Google Cloud)

New Google Cloud Medical Imaging Suite Makes Imaging Healthcare Data More Accessible

Medical imaging is a critical tool used to diagnose patients, and there are billions of medical images scanned globally each year. Imaging data accounts for about 90% of all healthcare data1 and, until... Read more
Copyright © 2000-2024 Globetech Media. All rights reserved.